Reviewing the therapeutic role of budesonide in Crohn's disease
Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide. Its approved indications are...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2018 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | español |
| OAI Identifier: | oai:ddd.uab.cat:287804 |
| Acceso en línea: | https://ddd.uab.cat/record/287804 https://dx.doi.org/urn:doi:10.1016/j.gastrohep.2018.05.013 |
| Access Level: | acceso abierto |
| Palabra clave: | Budesonida Budesonide Colitis ulcerosa Crohn's disease Enfermedad de Crohn Enfermedad inflamatoria intestinal Inflammatory bowel disease Ulcerative colitis |
| Sumario: | Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide. Its approved indications are reviewed, as well as other clinical scenarios in which it could play a role, in order to facilitate its use and improve the accuracy of its prescription. |
|---|